Stryker (NYSE:SYK) said yesterday that it priced a senior notes offering worth $3.5 billion. The 4-tranche flotation consists of $750 million in 3-year, 2.0% fixed notes due in March 2019; $750 million in 5-year 2.625% fixed notes due in March 2021; $1.0 billion in 10-year 3.5% fixed notes due in March 2026; and another $1.0 billion in 30-year 4.625% fixed notes […]
Resuscitation
FDA approves Zoll’s CPR device
UPDATED with comment from Zoll, trial investigator; trial details.
Zoll Medical inks deal for Impact Instrumentation
Zoll Medical today said it agreed to acquire Impact Instrumentation, which makes respiratory care devices, for an unspecified amount.
West Caldwell, N.J.-based Impact makes portable and automatic emergency ventilators, portable and onboard aspirators, custom mounting systems, and specialized testing systems, according to a press release.
Covidien recalls defibrillator electrodes
Zoll, Philips win Defense Dept. contracts
Appeals court denies Zoll challenge to Philips AED patents
Zoll Medical, Philips withdraw appeal in defibrillator patent spat
Zoll lands Japanese OK for R Series monitor/defibrillator
Zoll Medical said today that it won Shonin approval from the Japanese Ministry of Health, Labor & Welfare for its R Series combination monitor and automated external defibrillator.
FDA panel votes ‘yes’ on Advanced Circulatory’s new CPR tech
The FDA’s Circulatory System Devices Advisory Panel voted this month to recommend approval for Advanced Circulatory’s ResQCPR system for use during emergency CPR to help increase survival and minimize brain damage.
Press Release: Circulatory System Devices Advisory Panel Provides Favorable Recommendation to FDA on Risk-Benefit Profile of ResQCPR System
Advanced Circulatory Systems lands a date with the FDA
Minnesota medical device maker Advanced Circulatory Systems won a panel date with the FDA to review a PMA bid for its ResQCPR resuscitation systems.
